Roche Holding AG (ROP) - Total Liabilities

Latest as of December 2025: CHF62.82 Billion CHF ≈ $79.43 Billion USD

Based on the latest financial reports, Roche Holding AG (ROP) has total liabilities worth CHF62.82 Billion CHF (≈ $79.43 Billion USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Roche Holding AG annual equity growth to track the company's year-over-year net asset growth rate.

Roche Holding AG - Total Liabilities Trend (1998–2025)

This chart illustrates how Roche Holding AG's total liabilities have evolved over time, based on quarterly financial data. See how much free cash does Roche Holding AG generate to measure how efficiently the company converts operating cash flow to free cash.

Roche Holding AG Competitors by Total Liabilities

The table below lists competitors of Roche Holding AG ranked by their total liabilities.

Company	Country	Total Liabilities
UnitedHealth Group Incorporated NYSE:UNH	USA	$207.88 Billion
Toyota Motor Corporation ADR NYSE:TM	USA	$62.39 Trillion
AstraZeneca PLC F:ZEGA	Germany	€68.48 Billion
Wells Fargo & Company NYSE:WFC	USA	$2.03 Trillion
China Construction Bank Corporation F:C6T	Germany	€43.36 Trillion
Contemporary Amperex Technology Co Ltd Class A SHE:300750	China	CN¥652.10 Billion
RTX Corporation NYSE:RTX	USA	$102.40 Billion
Westpac Banking Corporation AU:WBCPI	Australia	AU$1.03 Trillion

Liability Composition Analysis (1998–2025)

This chart breaks down Roche Holding AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Roche Holding AG market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.38	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.86	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.62	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Roche Holding AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Roche Holding AG (1998–2025)

The table below shows the annual total liabilities of Roche Holding AG from 1998 to 2025.

Year	Total Liabilities	Change
2025-12-31	CHF62.82 Billion ≈ $79.43 Billion	-4.29%
2024-12-31	CHF65.64 Billion ≈ $82.99 Billion	+14.75%
2023-12-31	CHF57.20 Billion ≈ $72.32 Billion	+1.90%
2022-12-31	CHF56.14 Billion ≈ $70.97 Billion	-12.25%
2021-12-31	CHF63.97 Billion ≈ $80.88 Billion	+37.97%
2020-12-31	CHF46.37 Billion ≈ $58.62 Billion	-1.82%
2019-12-31	CHF47.22 Billion ≈ $59.70 Billion	-1.93%
2018-12-31	CHF48.15 Billion ≈ $60.88 Billion	+1.01%
2017-12-31	CHF47.67 Billion ≈ $60.27 Billion	-5.45%
2016-12-31	CHF50.42 Billion ≈ $63.74 Billion	-3.90%
2015-12-31	CHF52.46 Billion ≈ $66.33 Billion	-2.81%
2014-12-31	CHF53.98 Billion ≈ $68.25 Billion	+31.90%
2013-12-31	CHF40.93 Billion ≈ $51.74 Billion	-14.87%
2012-12-31	CHF48.08 Billion ≈ $60.78 Billion	+2.09%
2011-12-31	CHF47.09 Billion ≈ $59.54 Billion	-4.59%
2010-12-31	CHF49.36 Billion ≈ $62.40 Billion	-24.24%
2009-12-31	CHF65.15 Billion ≈ $82.37 Billion	+192.59%
2008-12-31	CHF22.27 Billion ≈ $28.15 Billion	-10.49%
2007-12-31	CHF24.88 Billion ≈ $31.45 Billion	-9.87%
2006-12-31	CHF27.60 Billion ≈ $34.89 Billion	-0.08%
2005-12-31	CHF27.62 Billion ≈ $34.92 Billion	+11.46%
2004-12-31	CHF24.78 Billion ≈ $31.33 Billion	-18.27%
2003-12-31	CHF30.32 Billion ≈ $38.34 Billion	-20.67%
2002-12-31	CHF38.22 Billion ≈ $48.32 Billion	-7.72%
2001-12-31	CHF41.42 Billion ≈ $52.36 Billion	+10.45%
2000-12-31	CHF37.50 Billion ≈ $47.41 Billion	-7.25%
1999-12-31	CHF40.43 Billion ≈ $51.11 Billion	+22.28%
1998-12-31	CHF33.06 Billion ≈ $41.80 Billion	--

About Roche Holding AG

SW:ROP Switzerland Drug Manufacturers - General

Market Cap

$309.29 Billion

CHF244.64 Billion CHF

Market Cap Rank

#73 Global

#2 in Switzerland

Share Price

CHF355.10

Change (1 day)

+1.60%

52-Week Range

CHF300.90 - CHF355.10

All Time High

CHF355.10